These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23102968)

  • 1. Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh.
    Sarker SA; McCallin S; Barretto C; Berger B; Pittet AC; Sultana S; Krause L; Huq S; Bibiloni R; Bruttin A; Reuteler G; Brüssow H
    Virology; 2012 Dec; 434(2):222-32. PubMed ID: 23102968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh.
    Sarker SA; Sultana S; Reuteler G; Moine D; Descombes P; Charton F; Bourdin G; McCallin S; Ngom-Bru C; Neville T; Akter M; Huq S; Qadri F; Talukdar K; Kassam M; Delley M; Loiseau C; Deng Y; El Aidy S; Berger B; Brüssow H
    EBioMedicine; 2016 Feb; 4():124-37. PubMed ID: 26981577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy.
    Bruttin A; Brüssow H
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2874-8. PubMed ID: 15980363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral application of Escherichia coli bacteriophage: safety tests in healthy and diarrheal children from Bangladesh.
    Sarker SA; Berger B; Deng Y; Kieser S; Foata F; Moine D; Descombes P; Sultana S; Huq S; Bardhan PK; Vuillet V; Praplan F; Brüssow H
    Environ Microbiol; 2017 Jan; 19(1):237-250. PubMed ID: 27750388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of Escherichia coli bacteriophages from the stool of pediatric diarrhea patients in Bangladesh.
    Chibani-Chennoufi S; Sidoti J; Bruttin A; Dillmann ML; Kutter E; Qadri F; Sarker SA; Brüssow H
    J Bacteriol; 2004 Dec; 186(24):8287-94. PubMed ID: 15576777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety analysis of a Russian phage cocktail: from metagenomic analysis to oral application in healthy human subjects.
    McCallin S; Alam Sarker S; Barretto C; Sultana S; Berger B; Huq S; Krause L; Bibiloni R; Schmitt B; Reuteler G; Brüssow H
    Virology; 2013 Sep; 443(2):187-96. PubMed ID: 23755967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic use of phage cocktail for controlling Escherichia coli O157:H7 in gastrointestinal tract of mice.
    Tanji Y; Shimada T; Fukudomi H; Miyanaga K; Nakai Y; Unno H
    J Biosci Bioeng; 2005 Sep; 100(3):280-7. PubMed ID: 16243277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy.
    Chibani-Chennoufi S; Sidoti J; Bruttin A; Kutter E; Sarker S; Brüssow H
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2558-69. PubMed ID: 15215109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T4 phages against Escherichia coli diarrhea: potential and problems.
    Denou E; Bruttin A; Barretto C; Ngom-Bru C; Brüssow H; Zuber S
    Virology; 2009 May; 388(1):21-30. PubMed ID: 19339031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coverage of diarrhoea-associated Escherichia coli isolates from different origins with two types of phage cocktails.
    Bourdin G; Navarro A; Sarker SA; Pittet AC; Qadri F; Sultana S; Cravioto A; Talukder KA; Reuteler G; Brüssow H
    Microb Biotechnol; 2014 Mar; 7(2):165-76. PubMed ID: 24528873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo replication of T4 and T7 bacteriophages in germ-free mice colonized with Escherichia coli.
    Weiss M; Denou E; Bruttin A; Serra-Moreno R; Dillmann ML; Brüssow H
    Virology; 2009 Oct; 393(1):16-23. PubMed ID: 19699505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From bench to bed and back again: phage therapy of childhood Escherichia coli diarrhea.
    Sarker SA; Brüssow H
    Ann N Y Acad Sci; 2016 May; 1372(1):42-52. PubMed ID: 27197768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome analysis of phage JS98 defines a fourth major subgroup of T4-like phages in Escherichia coli.
    Zuber S; Ngom-Bru C; Barretto C; Bruttin A; Brüssow H; Denou E
    J Bacteriol; 2007 Nov; 189(22):8206-14. PubMed ID: 17693496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification and purification of T4-like escherichia coli phages for phage therapy: from laboratory to pilot scale.
    Bourdin G; Schmitt B; Marvin Guy L; Germond JE; Zuber S; Michot L; Reuteler G; Brüssow H
    Appl Environ Microbiol; 2014 Feb; 80(4):1469-76. PubMed ID: 24362424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomics of staphylococcal Twort-like phages--potential therapeutics of the post-antibiotic era.
    Łobocka M; Hejnowicz MS; Dąbrowski K; Gozdek A; Kosakowski J; Witkowska M; Ulatowska MI; Weber-Dąbrowska B; Kwiatek M; Parasion S; Gawor J; Kosowska H; Głowacka A
    Adv Virus Res; 2012; 83():143-216. PubMed ID: 22748811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgA response of BALB/c mice to orally administered Salmonella typhimurium flagellin-displaying T2 bacteriophages.
    Synnott A; Ohshima K; Nakai Y; Tanji Y
    Biotechnol Prog; 2009; 25(2):552-8. PubMed ID: 19334277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and pharmacokinetics of NXN-188 after single and multiple doses in five phase I, randomized, double-blind, parallel studies in healthy adult volunteers.
    Vaughan D; Speed J; Medve R; Andrews JS
    Clin Ther; 2010 Jan; 32(1):146-60. PubMed ID: 20171420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of phage treatment as a strategy to reduce Salmonella populations in growing swine.
    Callaway TR; Edrington TS; Brabban A; Kutter B; Karriker L; Stahl C; Wagstrom E; Anderson R; Poole TL; Genovese K; Krueger N; Harvey R; Nisbet DJ
    Foodborne Pathog Dis; 2011 Feb; 8(2):261-6. PubMed ID: 21034249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward rational control of Escherichia coli O157:H7 by a phage cocktail.
    Tanji Y; Shimada T; Yoichi M; Miyanaga K; Hori K; Unno H
    Appl Microbiol Biotechnol; 2004 Apr; 64(2):270-4. PubMed ID: 13680205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteriophage isolated from feedlot cattle can reduce Escherichia coli O157:H7 populations in ruminant gastrointestinal tracts.
    Callaway TR; Edrington TS; Brabban AD; Anderson RC; Rossman ML; Engler MJ; Carr MA; Genovese KJ; Keen JE; Looper ML; Kutter EM; Nisbet DJ
    Foodborne Pathog Dis; 2008 Apr; 5(2):183-91. PubMed ID: 18407757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.